Specialty Pharmacy Leveraging Disease Management and Technology to Help Multiple Sclerosis Patients Adhere to Treatment Plan
According to a 2015 study of 209 Multiple Sclerosis (MS) patients using the MS Treatment Adherence Questionnaire, compliance to treatment regardless of medication type—SC/IM, monthly IV injections, or oral DMTs—continues to be a major challenge.
Enroll 1647 MS patients on SC/IM therapy into CareMed’s MS disease management program to assess medication compliance. Measure outcomes using the MS Treatment Adherence Questionnaire (MS-TAQ) and compare to 2015 study compliance results (70.8%). Leverage technology to analyze results and pro-actively engage patients. Key measures/outcomes assessed: (1) number of missed doses in four weeks; (2) reason dose was missed; (3) perceived side effects; (4) ease of administration; and (5) medication satisfaction
Of the 1647 enrolled MS patients on SC/IM therapy, only 43 missed a dose(s) due to the following issues: (1) fogot; (2) fatigue; (3) financial; (4) flu like symptom; and (5) other. 1604 of patients on SC/IM did not miss a dose.